CHA BIOTECH aims to provide advanced biomedical solutions to today's incurable diseases.
Through its extensive global network of multidisciplinary research institutes, biotechnology
company, medical university and hospitals in both the United States and Korea, the team at
CHA HEALTH SYSTEMS is on the cutting-edge of stem cell research and the clinical applications of stem cells. Starting from a 30-year history in fertility and oocyte-freezing research, CHA
BIOTECH has dedicated its resources to advancing scientific technology in stem cell research
into clinical products today.

Research Focuses

• Production of embryonic stem cell lines • Embryonic stem cell-derived cell therapies • Oocyte banking • Adult stem cell-derived cell therapies • Tissue Engineering/Regenerative Medicine • Production of disease-specific animal models • Public cord blood bank • Toxicity screening systems • Cancer therapies (LA)